Dry Eye Syndrome Market Growth To $5.95 Billion By 2030: What’s Driving The Expansion?
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Dry Eye Syndrome Market Growth Potential: How Will Market Size Shift Through 2030?
The dry eye syndrome market has shown significant expansion in recent years. It is projected to grow from $4.17 billion in 2025 to $4.45 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. This past growth can be attributed to factors such as the increasing prevalence of dry eye syndrome, an expanding geriatric population, a rise in screen time and the use of digital devices, greater awareness of eye health, and developments in artificial tear formulations.
The dry eye syndrome market is anticipated to experience significant expansion in the coming years. Its valuation is projected to reach $5.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.5%. This growth over the forecast period can be attributed to the advancement of novel drug delivery systems, the expansion of personalized medicine, an increase in the adoption of wearable eye care devices, the broadening of online pharmacy channels, and heightened research into natural and herbal eye care products. Key trends for the forecast period include advanced tear film diagnostics, innovative drug delivery systems, customized dry eye treatments, natural and herbal formulations, and wearable eye care devices.
Get A Free Sample Report With In-Depth Market Insights:
Dry Eye Syndrome Market Expansion Drivers: What’s Shaping Future Growth?
The increasing older demographic is anticipated to fuel the expansion of the dry eye syndrome market in the future. This demographic trend signifies a rising percentage of older people within a society, and it contributes to the growth of dry eye syndrome because a greater number of older individuals will correspond to a higher need for effective remedies and treatments for this widespread condition. For example, the World Health Organization (WHO), a United Nations (UN) entity based in Switzerland, reported in October 2025 that by 2030, one in six people worldwide will be 60 or older, and this age group’s population is expected to reach 2.1 billion by 2050, effectively doubling. Consequently, the expanding older demographic is stimulating the growth of the dry eye syndrome market.
Dry Eye Syndrome Market Segment Breakdown: Which Categories Lead On Revenue?
The dry eye syndrome market covered in this report is segmented –
1) By Product: Liquid Drops, Gel, Liquid Wipes, Eye Ointment, Other Products
2) By Treatment: Corticosteroids, Artificial Tears, Oral Omega Supplements, Lubricating Agent, Other Treatments
3) By Disease Type: Evaporative, Aqueous
4) By Distribution Channel: Offline, Online
5) By Application: Hospitals And Clinics, Medical Laboratories, Other Applications
Subsegments:
1) By Liquid Drops: Preservative-Free Drops, Preserved Liquid Drops, Antibiotic-Infused Drops
2) By Gel: Long-Lasting Gels, Hydrogel Formulations
3) By Liquid Wipes: Pre-Moistened Wipes, Anti-Bacterial Wipes
4) By Eye Ointment: Night-Time Ointments, Therapeutic Ointments
5) By Other Products: Eye Masks, Contact Lens Solutions, Nutritional Supplements
Dry Eye Syndrome Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies within the dry eye syndrome market are concentrating on developing advanced solutions, such as nanomicellar drug delivery technology, to improve treatment efficacy and enhance patient comfort. This nanomicellar drug delivery method utilizes tiny micelles to boost the penetration of active ingredients into ocular tissues, supporting quicker therapeutic action. The objective of this strategy is to overcome the limitations of current treatments and address the substantial unmet demand in dry eye disease. For example, in April 2023, Sun Pharma, an India-based pharmaceutical company, introduced CEQUA, which incorporates NCELL nanomicellar technology. This product is the first dry eye treatment in India delivered using this technology, offering superior delivery compared to cyclosporine emulsion 0.05 percent. It is supported by several years of clinical experience acquired in the United States and other geographies, providing faster results alongside good patient comfort from the initiation of treatment. The launch is a response to the increasing prevalence of dry eye disease in India, where extended screen time has contributed to a rise in cases and is projected to expand the disease burden in the coming years.
Dry Eye Syndrome Market Leading Players And Competitive Positioning
Major companies operating in the dry eye syndrome market are Allergan plc, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Santendo Pharmaceutical Co. Ltd., Sentiss Pharma Pvt. Ltd., Johnson & Johnson, Alcon Vision LLC, Akorn Operating Company LLC, Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., AbbVie Inc., I-MED Pharma Inc., AFT Pharmaceuticals, Horus Pharma, Novaliq GmbH, OASIS Medical, Prestige Consumer Healthcare, VISUfarma, Alimera Science, Kala Pharmaceuticals Inc., Nicox S.A., EyeGate Pharmaceuticals Inc., ReVision Therapeutics Inc., Itear Medical
View The Full Dry Eye Syndrome Market Report:
Dry Eye Syndrome Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the dry eye syndrome market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global dry eye syndrome market report during the forecast period. The regions covered in the dry eye syndrome market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
